These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3366400)
1. [Digoxin-like material in liver disease]. Shilo L; Shapiro MS; Shenkman L Harefuah; 1988 Mar; 114(5):224-5. PubMed ID: 3366400 [No Abstract] [Full Text] [Related]
2. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results]. Romano L; Zofra S; Imperato G; Adorno V; Maglione A Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060 [No Abstract] [Full Text] [Related]
3. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay. Lacarelle B; Durand A; Labadie N; Cano JP Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757 [No Abstract] [Full Text] [Related]
4. Evidence of marked digoxin-like immunoreactivity in the human adrenal cortex: results of an immunohistochemical study. Ghione S; Balzan S; Braus S; Montali U; Bruno J Eur J Histochem; 1993; 37(3):273-6. PubMed ID: 7693066 [TBL] [Abstract][Full Text] [Related]
5. Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay. Kulaots IA; Pudek MR; Seccombe DW Clin Chem; 1987 Aug; 33(8):1490-1. PubMed ID: 3301074 [No Abstract] [Full Text] [Related]
6. Endogenous digoxin-like substance(s) and combined hepatic and renal failure. Gault MH; Vasdev SC; Longerich LL Ann Intern Med; 1984 Oct; 101(4):567-8. PubMed ID: 6548099 [No Abstract] [Full Text] [Related]
7. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone? Clerico A; Ghione S; Balzan S; Del Chicca MG J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187 [No Abstract] [Full Text] [Related]
8. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS. Gervais A; Nanji AA; Greenway DC; McLean W Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173 [TBL] [Abstract][Full Text] [Related]
9. Digoxin-like immunoreactive substances and bile acids in the serum of patients with liver disease. Pudek MR; Seccombe DW; Humphries K Clin Chem; 1986 Oct; 32(10):2005-6. PubMed ID: 3757258 [No Abstract] [Full Text] [Related]
10. Digitoxin antibody cross-reactivity and evaluation of potential candidates for circulating digitalis-like immunoreactive factor. Graves SW; Naomi S; Williams GH; Hollenberg NK Clin Chem; 1994 Oct; 40(10):1977-8. PubMed ID: 7923784 [No Abstract] [Full Text] [Related]
11. [The role of endogenous digoxin-like substance in the pathogenesis of arterial hypertension in pregnancy]. Soszyński P; Słowińska-Srzednicka J; Latoszewska-Smółko W Pol Tyg Lek; 1987 Sep; 42(37):1145-8. PubMed ID: 3432148 [No Abstract] [Full Text] [Related]
12. [Endogenous digitalis-like substance. II. Relation to pathologic states and diseases]. Martinka E Vnitr Lek; 1995 Oct; 41(10):719-23. PubMed ID: 8578707 [TBL] [Abstract][Full Text] [Related]